Sunshine Biopharma SBFM
NASDAQ SBFM
$2.75 +0.04 (+1.48%)
At close: Nov 9, 2026 · 4:00 PM EST

Sunshine Biopharma (SBFM) Interest & Investment Income (2021 - 2026)

Updated

Sunshine Biopharma (SBFM) reported Interest & Investment Income of $48,816 for Q2 2026, down 32.9% from $72,715 a year earlier.

Analysis

Sunshine Biopharma (SBFM) Interest & Investment Income (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Sunshine Biopharma's Interest & Investment Income came in at $121,533; for FY2020, it came in at $2,836, up 107.5% from FY2019.

  • By year, Interest & Investment Income came in at $1,367 in FY2019.
  • The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 186.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Sunshine Biopharma 187,731.50 -38.90 Mn 2.43 Mn 48,816.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48,816.00
Jun 30, 2025 72,715.00
Jun 30, 2021 2.00
API Access

Sunshine Biopharma Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SBFM&period=max&api_key=YOUR_API_KEY